Moleculin Biotech (MBRX) Operating Expenses (2016 - 2026)
Moleculin Biotech's Operating Expenses was $7.56 million in Q2 2026, up 32.2% from $5.72 million a year earlier.
Powered by 
Analysis
Moleculin Biotech (MBRX) Operating Expenses (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Moleculin Biotech's Operating Expenses was $26.72 million through Jun 30, 2026, up 5.0% year-over-year; for FY2025, it came in at $25.1 million, down 5.8% from FY2024.
- Operating Expenses has now declined for three consecutive years, though with a five-year compound annual growth rate of 4.9% (FY2020 to FY2025).
- In earlier years, Operating Expenses was $26.64 million in FY2024 (-10.1%), $29.63 million in FY2023 (-3.3%), $30.64 million in FY2022 (+33.4%) and $22.97 million in FY2021 (+16.3%).
- The Q2 2026 figure marks the highest quarterly Operating Expenses since Q4 2023.
- Compared with a year earlier, Operating Expenses was higher in three of the last seven quarters, with growth averaging 0.6%.
- The best year-over-year quarter for Operating Expenses over five years was Q4 2021 (growth of 48.9%); the worst was Q3 2023 (a decline of 34.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.09 Bn |
| 10 | Moleculin Biotech | 3.24 Mn | 3.24 Mn | - | 7.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.56 Mn |
| Dec 31, 2025 | 7.53 Mn |
| Sep 30, 2025 | 5.91 Mn |
| Jun 30, 2025 | 5.72 Mn |
| Mar 31, 2025 | 5.94 Mn |
| Dec 31, 2024 | 6.64 Mn |
| Sep 30, 2024 | 7.14 Mn |
| Jun 30, 2024 | 6.19 Mn |
| Mar 31, 2024 | 6.68 Mn |
| Dec 31, 2023 | 8.92 Mn |
| Sep 30, 2023 | 5.95 Mn |
| Jun 30, 2023 | 6.41 Mn |
| Mar 31, 2023 | 8.35 Mn |
| Dec 31, 2022 | 7.05 Mn |
| Sep 30, 2022 | 9.08 Mn |
| Jun 30, 2022 | 7.43 Mn |
| Mar 31, 2022 | 7.07 Mn |
| Dec 31, 2021 | 5.21 Mn |
| Sep 30, 2021 | 6.16 Mn |
| Jun 30, 2021 | 5.52 Mn |
API Access
Moleculin Biotech Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=MBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "MBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=MBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();